This Funding Opportunity Announcement (FOA) invites applications to develop and implement Phase Ib to III clinical trials of promising pharmacological and non-pharmacological interventions that may prevent, delay, or treat the symptoms of Alzheimer's disease (AD) and other age-related dementias
credit:
using the Alzheimer's disease Clinical Trials Consortium (ACTC) trial coordination and management infrastructure.